Financials
Income statement
| Fiscal date | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 |
|---|---|---|---|---|
| Total reported revenue | — | 9.3B | 8.1B | 8.7B |
| Cost of revenue | — | 5.8B | 5.1B | 5.4B |
| Gross profit | — | 3.5B | 3.0B | 3.3B |
| Operating expense | ||||
| Research & development | — | 965M | 898M | 888M |
| Selling general and admin | — | 318M | 285M | 288M |
| Other operating expenses | — | 56M | 7M | -2M |
| Operating income | — | 2.2B | 1.8B | 2.2B |
| Non operating interest income | ||||
| Income | — | 135M | 108M | 107M |
| Expense | — | 123M | 112M | 118M |
| Other income expense | — | -68M | -11M | -11M |
| Pretax income | — | 2.1B | 1.8B | 2.2B |
| Tax provision | — | 235M | 177M | 283M |
| Net income | — | 1.9B | 1.6B | 1.9B |
| Basic EPS | 2.9 | 1.7 | 1.4 | 1.7 |
| Diluted EPS | 2.8 | 1.7 | 1.4 | 1.7 |
| Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
| Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
| EBITDA | — | 4.3B | 3.9B | 4.3B |
| Net income from continuing op. | — | 1.9B | 1.6B | 1.9B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |